Cancer News and Research

Latest Cancer News and Research

UT Southwestern Medical Center ranks among the top 50 hospitals

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth – the nation's fourth-largest metro area – and ranks among the top 50 hospitals nationally in 10 specialties ranging from brain to heart care, according to U.S. News & World Report's annual Best Hospitals report released today. Six of the specialties rank in the top 25.

28 Jul 2020

Study could lead to treatments that prevent deadly metastasis

Tiny finger-like projections called filopodia drive invasive behavior in a rare subset of lung cancer cells, researchers at Winship Cancer Institute of Emory University have found.

28 Jul 2020

Cancer-related care has decreased since the start of COVID-19

Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.

28 Jul 2020

A new perspective on lung cancer

Perspectives in Lung Cancer is the first volume of Bentham Books new series, Frontiers in Lung Cancer. The new book, edited by Dr. Keyvan Moghissi et al., is a comprehensive compilation of basic and advanced topics on lung cancer pathology and treatment in a single volume.

28 Jul 2020

Simultaneous mutation of two nonessential genes can cause cancer cell death

A Ludwig Cancer Research study has identified a new instance in which the simultaneous mutation of two nonessential genes - neither of which is on its own vital to cell survival - can cause cancer cell death.

28 Jul 2020

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

The U.S. Food and Drug Administration granted accelerated approval for brexucabtagene autoleucel (TECARTUS™, formerly KTE-X19) as the first and only CAR T-cell therapy for patients with mantle cell lymphoma (MCL) relapsed or refractory to prior treatments.

28 Jul 2020

Exploiting 'synthetic lethality' to identify cancer targets

With advances in genome sequencing, cancer treatments have increasingly sought to leverage the idea of "synthetic lethality," exploiting cancer-specific genetic defects to identify targets that are uniquely essential to the survival of cancer cells.

28 Jul 2020

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

27 Jul 2020

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

A vaccine candidate for preventing COVID-19 is advancing to a 30,000-participant phase 3 trial that begins today, and Brigham and Women's Hospital will play two key roles in the trial's next phase.

27 Jul 2020

Novel label-free imaging method can differentiate active T cells from those off duty

T cells are the immune soldiers at the frontlines of the battle with infiltrating pathogens that seek to cause disease. A new study published in Nature Biomedical Engineering describes a novel label-free imaging technique that can differentiate active T cells from those off duty.

27 Jul 2020

$Study finds link between fewer hip fractures and decreases in smoking, heavy drinking$

Study finds link between fewer hip fractures and decreases in smoking, heavy drinking

A new study, which analyzed 40 years of Framingham Heart Study data, found an association between lowered rates of hip fractures and decreases in smoking and heavy drinking.

27 Jul 2020

Flu vaccine may lower chances of getting Alzheimer's disease

People who received at least one flu vaccination were 17% less likely to get Alzheimer's disease over the course of a lifetime, according to researchers at The University of Texas Health Science Center at Houston.

27 Jul 2020

NIDA funding allows Temple scientists to continue critical substance abuse research

Substance abuse is a major public health problem in the United States, with some 21 million Americans diagnosed with at least one substance use disorder.

27 Jul 2020

Population screening has potential to identify individuals at risk for inherited genetic conditions

In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke.

27 Jul 2020

EBV viral genome alters the host epigenetic landscape to drive stomach cancer

The Epstein-Barr virus (EBV), one of the most common human viruses, is associated with about 8-10 per cent of stomach -- or gastric -- cancers, the third leading cause of cancer death globally.

27 Jul 2020

Pathological regression of lymph nodes better predicts survival in esophageal cancer patients

A group of researchers led by Osaka University established a new pathological grading system to evaluate the therapeutic effect of neoadjuvant chemotherapy for metastatic lymph nodes removed in esophageal cancer surgery, demonstrating that the system predicts recurrence and prognosis in EC patients better than conventional systems.

27 Jul 2020

Researchers find link between healthy diet and lower risk of prostate cancer

The Canadian Cancer Society estimates that more than 23,000 Canadians will be diagnosed with prostate cancer in 2020. Among other risk factors, more and more studies point to diet as a major factor in the development of prostate cancer, as it is for cardiovascular disease, diabetes, and obesity.

27 Jul 2020

Cancers caused by bacterial toxin might be preventable

Studying DNA mutations in cancers can help clarify how cancers develop and what makes cancer cells different from normal, healthy cells.

27 Jul 2020

The color of COVID: Will vaccine trials reflect America’s diversity?

When U.S. scientists launch the first large-scale clinical trials for COVID-19 vaccines this summer, Antonio Cisneros wants to make sure people like him are included.

27 Jul 2020

National clinical trial to test potential vaccine against SARS-CoV-2

UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.

25 Jul 2020

Cancer News and Research

Latest Cancer News and Research

UT Southwestern Medical Center ranks among the top 50 hospitals

Study could lead to treatments that prevent deadly metastasis

Cancer-related care has decreased since the start of COVID-19

A new perspective on lung cancer

Simultaneous mutation of two nonessential genes can cause cancer cell death

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

Exploiting 'synthetic lethality' to identify cancer targets

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

Novel label-free imaging method can differentiate active T cells from those off duty

Study finds link between fewer hip fractures and decreases in smoking, heavy drinking

Flu vaccine may lower chances of getting Alzheimer's disease

NIDA funding allows Temple scientists to continue critical substance abuse research

Population screening has potential to identify individuals at risk for inherited genetic conditions

EBV viral genome alters the host epigenetic landscape to drive stomach cancer

Pathological regression of lymph nodes better predicts survival in esophageal cancer patients

Researchers find link between healthy diet and lower risk of prostate cancer

Cancers caused by bacterial toxin might be preventable

The color of COVID: Will vaccine trials reflect America’s diversity?

National clinical trial to test potential vaccine against SARS-CoV-2

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in